Last reviewed · How we verify
NCT03481036
DAA Therapy in Pediatric Patients With Chronic Hepatitis C
NA trial testing Direct Acting Antivirals in Chronic Hepatitis c in 100 participants. Status unknown.
31 December 2020
Quick facts
| Lead sponsor | Post Graduate Institute of Medical Education and Research, Chandigarh |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 18 June 2016 |
| Primary completion | 31 December 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across India |
Drugs / interventions tested
- Direct Acting Antivirals — full drug profile →
- DAAs in Cirrhotics Genotype 2/3 — full drug profile →
- DAAs in Cirrhotics Genotye 1,4,5,6 — full drug profile →
Conditions studied
- Chronic Hepatitis c — all drugs for Chronic Hepatitis c →
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Who can join
Adults 12 to 18, any sex, with Chronic Hepatitis c. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Mukh-Mantri Punjab Hepatitis C Relief Fund (MMPHCRF) is a public health initiative for prevention and control of hepatitis C in the Punjab state, India. The efficacy of decentralised public health services and safety of 12- or 24-weeks of sofosbuvir (SOF) + ledipasvir (LDV) or SOF + daclatasvir (DCV) with or without ribavirin (RBV) in the treatment of pediatric chronic hepatitis C will be assessed
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Hepatitis C virus infection in mothers and children.
Greenaway E, Biondi MJ, Feld JJ, Ling SC. · · 2019 · cited 4× · PMID 35992762 · DOI 10.3138/canlivj.2019-0009
Verify or expand the search:
- PubMed search for NCT03481036
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Direct Acting Antivirals
Trials testing the same drug.
- NCT05372874 — Treatment of Hepatitis c by Using Direct-acting Antiviral · unknown
- NCT05368974 — The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry · recruiting
- NCT04320290 — HCV + to HCV - Kidney Transplant · Phase 4 · withdrawn
- NCT03894696 — Frequency of Anxiety and Depression in Chronic Hepatitis C Patients Recieving Direct-Acting Antiviral Agents · unknown
- NCT03702218 — Hepatitis C Positive Donor Into Hepatitis C Negative Recipients · EARLY_PHASE1 · withdrawn
Other Post Graduate Institute of Medical Education and Research, Chandigarh trials
Trials by the same sponsor.
- NCT07322237 — DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis · Phase 4 · recruiting
- NCT07436988 — Affordable Made-in-India Microspheres for Liver Cancer Therapy · Phase 1 · not yet recruiting
- NCT07286643 — Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis · NA · recruiting
- NCT07280390 — Microplastics, Cirrhosis and Portal Hypertension · not yet recruiting
- NCT07182877 — Comparison of Dwell Time of Open Versus Closed Type Peripheral Intravenous Cannula · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03481036 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Post Graduate Institute of Medical Education and Research, Chandigarh
- Last refreshed: 17 June 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03481036.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing